These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 31915880)

  • 1. [Exosomes: potential liquid biopsy in head and neck cancer].
    Theodoraki MN; Ludwig S
    HNO; 2020 Feb; 68(2):106-110. PubMed ID: 31915880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic and Therapeutic Applications of Exosomes in Cancer with a Special Focus on Head and Neck Squamous Cell Carcinoma (HNSCC).
    Ebnoether E; Muller L
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32570802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD44v3 protein-carrying tumor-derived exosomes in HNSCC patients' plasma as potential noninvasive biomarkers of disease activity.
    Theodoraki MN; Matsumoto A; Beccard I; Hoffmann TK; Whiteside TL
    Oncoimmunology; 2020; 9(1):1747732. PubMed ID: 32313730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid biopsy in head and neck squamous cell carcinoma: circulating tumor cells, circulating tumor DNA, and exosomes.
    Yang WY; Feng LF; Meng X; Chen R; Xu WH; Hou J; Xu T; Zhang L
    Expert Rev Mol Diagn; 2020 Dec; 20(12):1213-1227. PubMed ID: 33232189
    [No Abstract]   [Full Text] [Related]  

  • 5. The Emerging Role of Exosomes in Diagnosis, Prognosis, and Therapy in Head and Neck Cancer.
    Hofmann L; Ludwig S; Vahl JM; Brunner C; Hoffmann TK; Theodoraki MN
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32517240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Potential of CD16 on Plasma-Derived Exosomes as a Liquid Biomarker in Head and Neck Cancer.
    Hofmann L; Ludwig S; Schuler PJ; Hoffmann TK; Brunner C; Theodoraki MN
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32466374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptome reprogramming by cancer exosomes: identification of novel molecular targets in matrix and immune modulation.
    Qadir F; Aziz MA; Sari CP; Ma H; Dai H; Wang X; Raithatha D; Da Silva LGL; Hussain M; Poorkasreiy SP; Hutchison IL; Waseem A; Teh MT
    Mol Cancer; 2018 Jul; 17(1):97. PubMed ID: 30008265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liquid biopsy: An emerging prognostic and predictive tool in Head and Neck Squamous Cell Carcinoma (HNSCC). Focus on Circulating Tumor Cells (CTCs).
    Economopoulou P; Kotsantis I; Kyrodimos E; Lianidou ES; Psyrri A
    Oral Oncol; 2017 Nov; 74():83-89. PubMed ID: 29103757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purine Metabolites in Tumor-Derived Exosomes May Facilitate Immune Escape of Head and Neck Squamous Cell Carcinoma.
    Ludwig N; Gillespie DG; Reichert TE; Jackson EK; Whiteside TL
    Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32560461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune Suppressive Effects of Plasma-Derived Exosome Populations in Head and Neck Cancer.
    Beccard IJ; Hofmann L; Schroeder JC; Ludwig S; Laban S; Brunner C; Lotfi R; Hoffmann TK; Jackson EK; Schuler PJ; Theodoraki MN
    Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32708274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomes of exosomes from HPV(+) or HPV(-) head and neck cancer cells: differential enrichment in immunoregulatory proteins.
    Ludwig S; Marczak L; Sharma P; Abramowicz A; Gawin M; Widlak P; Whiteside TL; Pietrowska M
    Oncoimmunology; 2019; 8(7):1593808. PubMed ID: 31143515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosomes in HNSCC plasma as surrogate markers of tumour progression and immune competence.
    Theodoraki MN; Hoffmann TK; Jackson EK; Whiteside TL
    Clin Exp Immunol; 2018 Oct; 194(1):67-78. PubMed ID: 30229863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Separation of plasma-derived exosomes into CD3
    Theodoraki MN; Hoffmann TK; Whiteside TL
    Clin Exp Immunol; 2018 Jun; 192(3):271-283. PubMed ID: 29431869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The development of a liquid biopsy for head and neck cancers.
    Schmidt H; Kulasinghe A; Kenny L; Punyadeera C
    Oral Oncol; 2016 Oct; 61():8-11. PubMed ID: 27688098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Annexin A1 regulates EGFR activity and alters EGFR-containing tumour-derived exosomes in head and neck cancers.
    Raulf N; Lucarelli P; Thavaraj S; Brown S; Vicencio JM; Sauter T; Tavassoli M
    Eur J Cancer; 2018 Oct; 102():52-68. PubMed ID: 30142511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential Immunomodulatory Effects of Head and Neck Cancer-Derived Exosomes on B Cells in the Presence of ATP.
    Coray M; Göldi V; Schmid L; Benecke L; Figueiró F; Muller L
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential of tumor-derived exosomes for noninvasive cancer monitoring: an update.
    Whiteside TL
    Expert Rev Mol Diagn; 2018 Dec; 18(12):1029-1040. PubMed ID: 30406709
    [No Abstract]   [Full Text] [Related]  

  • 18. Circulating exosomes measure responses to therapy in head and neck cancer patients treated with cetuximab, ipilimumab, and IMRT.
    Theodoraki MN; Yerneni S; Gooding WE; Ohr J; Clump DA; Bauman JE; Ferris RL; Whiteside TL
    Oncoimmunology; 2019; 8(7):1593805. PubMed ID: 31143513
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical Significance of PD-L1
    Theodoraki MN; Yerneni SS; Hoffmann TK; Gooding WE; Whiteside TL
    Clin Cancer Res; 2018 Feb; 24(4):896-905. PubMed ID: 29233903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cargo and Functional Profile of Saliva-Derived Exosomes Reveal Biomarkers Specific for Head and Neck Cancer.
    Hofmann L; Medyany V; Ezić J; Lotfi R; Niesler B; Röth R; Engelhardt D; Laban S; Schuler PJ; Hoffmann TK; Brunner C; Jackson EK; Theodoraki MN
    Front Med (Lausanne); 2022; 9():904295. PubMed ID: 35899209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.